RLF — RELIEF THERAPEUTICS Holding SA Cashflow Statement
0.000.00%
Last trade - 00:00
- CH₣29.47m
- CH₣21.16m
- CH₣6.03m
- 10
- 32
- 44
- 17
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -7.46 | -7.83 | -34.7 | -50.8 | -98.2 |
Depreciation | |||||
Non-Cash Items | 6.7 | -10.5 | 2.19 | 17.2 | 78.2 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.028 | 0.028 | -5.23 | 5.59 | -0.991 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -0.728 | -18.3 | -35.7 | -24.1 | -17.6 |
Capital Expenditures | — | — | -13.7 | -0.521 | -0.446 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | 3 | -16.6 | -7.48 | 9.14 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | — | 3 | -30.3 | -8 | 8.7 |
Financing Cash Flow Items | — | -0.634 | -2.85 | -0.223 | -0.494 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.6 | 58.2 | 67.7 | 6.42 | 4.05 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.128 | 43 | 1.61 | -25.5 | -4.68 |